Format

Send to:

Choose Destination
See comment in PubMed Commons below
Stat Med. 2008 Nov 20;27(26):5392-406. doi: 10.1002/sim.3367.

Noninferiority hypotheses and choice of noninferiority margin.

Author information

  • 1US Food and Drug Administration, 1401 Rockville Pike, #200S, HFM-219, Rockville, MD 20852-1448, USA. tiehua.ng@fda.hhs.gov

Abstract

Ng (Drug Inf. J. 1993; 27:705-719; Drug Inf. J. 2001; 35:1517-1527) proposed that the noninferiority (NI) margin should be a small fraction of the therapeutic effect of the active control as compared with placebo in the setting of testing the NI hypothesis of the mean difference with a continuous outcome. For testing the NI hypothesis of the mean ratio with a continuous outcome, a similar NI margin on a log scale is proposed. This approach may also be applied in the setting of testing the NI hypotheses for survival data based on hazard ratios. Some pitfalls of testing the NI hypotheses with binary endpoints based on the difference or the ratio of proportions will be discussed. Testing the NI hypothesis with binary endpoints based on the odds ratio is proposed.

PMID:
18680173
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk